Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between SMS Pharmaceuticals IPO and Transwarranty IPO.
SMS Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Transwarranty IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
| SMS Pharmaceuticals IPO | Transwarranty IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Book Built Issue | Book Built Issue |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Uti Securities Ltd | Idbi Capital Market Services Limited |
| Registrar | Aarthi Consultants Pvt Ltd. | Link Intime India Private Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
IPO Allotment URL |
The total issue size of SMS Pharmaceuticals IPO is up to ₹97.93 Cr whereas the issue size of the Transwarranty IPO is up to ₹31.20 Cr. The final issue price of SMS Pharmaceuticals IPO is ₹380.00 per share and of Transwarranty IPO is ₹52.00 per share.
| SMS Pharmaceuticals IPO | Transwarranty IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹360.00 per share | ₹48.00 per share |
| Issue Price (Upper) | ₹380.00 per share | ₹55.00 per share |
| Issue Price (Final) | ₹380.00 per share | ₹52.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 15 shares | 120 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 25,77,000 shares | 60,00,000 shares |
| Issue Size Total (Amount) | up to ₹97.93 Cr | up to ₹31.20 Cr |
SMS Pharmaceuticals IPO opens on Feb 05, 2007, while Transwarranty IPO opens on Jan 23, 2007. The closing date of SMS Pharmaceuticals IPO and Transwarranty IPO is Feb 08, 2007, and Feb 02, 2007, respectively.
| SMS Pharmaceuticals IPO | Transwarranty IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Feb 05, 2007 | Jan 23, 2007 |
| Issue Close | Feb 08, 2007 | Feb 02, 2007 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
SMS Pharmaceuticals IPO P/E ratio is , as compared to Transwarranty IPO P/E ratio of .
| SMS Pharmaceuticals IPO | Transwarranty IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the SMS Pharmaceuticals IPO retail investors (RII) are offered while in Transwarranty IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in SMS Pharmaceuticals IPO and in Transwarranty IPO.
| SMS Pharmaceuticals IPO | Transwarranty IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
SMS Pharmaceuticals IPO subscribed 2.64x in total, whereas Transwarranty IPO subscribed 1.59x.
| SMS Pharmaceuticals IPO | Transwarranty IPO | |
|---|---|---|
| QIB (times) | 3.47x | 1.03x |
| NII (times) | 0.28x | 1.87x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.47x | 2.34x |
| Employee (times) | 0.24x | |
| Other (times) | ||
| Total (times) | 2.64x | 1.59x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
